Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small blood vessels are components of the vasculature consisting mainly of capillaries, which are composed of an endothelial cell monolayer and a basal lamina, sometimes surrounded by pericytes. Arterioles and venules, while slightly larger, are often grouped with capillaries as microvessels for pathological or pharmacological discussion. Capillaries are involved in gas and nutrient exchange, waste removal, and play critical roles in inflammation, angiogenesis, and wound healing. Structural types include continuous, fenestrated, and sinusoidal capillaries, each adapted to specific tissue and organ needs. In disease, microvasculature is central to pathologies such as diabetes, cancer (where microvessel density is a biomarker), and cardiovascular disease. While drugs can target cells within small blood vessels (such as antiangiogenics targeting endothelial cell proliferation in tumors), "small blood vessels" themselves are not a molecular or single receptor target and thus cannot be classified as a canonical "target" for therapy[2][3][5][1]. Key clarifications: - "Small blood vessels" is not a canonical molecule or receptor, nor a singular protein/gene product; it describes a structural class of tissues made up of various cell types (endothelial cells, pericytes, basement membrane). - All subsequent molecular, drug, biomarker or disease roles relate primarily to features or pathophysiology of these vessels rather than to "small blood vessels" as a single molecular target. For future structuring, consider using "Capillary" or specifying cell or molecular targets (e.g., "Endothelial cell (of capillary blood vessel)", "VEGF receptor", etc.) if a true molecular target is intended.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small Blood Vessels.